GlassScriptPhysician profile
Robert Brian Huff
NPI 1134157779
$12,510.44
in general payments reported to CMS, 2019-2025
34 companies · $2,755 in 2025
The $2,755 reported for 2025 was more than what 91% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,526 · 2020: $907 · 2021: $1,220 · 2022: $1,650 · 2023: $2,026 · 2024: $2,427 · 2025: $2,755.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,207.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,879.56 | 2019-2025 | Clareon, Centurion, Rocklatan |
| Abbvie INC. | $1,883.97 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $1,540.25 | 2019-2025 | Cequa, Xelpros |
| Bausch & Lomb Americas INC. | $736.39 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Novartis Pharmaceuticals Corporation | $588.59 | 2019-2023 | |
| Johnson & Johnson Surgical Vision, INC. | $516.63 | 2019-2025 | Catalys System, Veritas Vision System, Tecnis Iol |
| Mallinckrodt Hospital Products INC. | $414.54 | 2020-2025 | Acthar |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $407.88 | 2019-2021 | |
| Kala Pharmaceuticals, INC. | $388.28 | 2019-2022 | |
| Glaukos Corporation | $357.79 | 2019-2025 | Idose, Idosetr, Istent Inject Trabecular Micro-Bypass System Model G2-M-Is |
| Ocular Therapeutix, INC. | $317.83 | 2019-2024 | Dextenza |
| Sight Sciences, INC. | $315.81 | 2021-2025 | Omni Surgical System, Sion Surgical Instrument |
| New World Medical,INC. | $284.76 | 2019-2025 | Kahook Dual Blade, Ahmed Glaucoma Valve, Streamline |
| Oyster Point Pharma, INC. | $259.55 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Tarsus Pharmaceuticals, INC. | $249.41 | 2024-2025 | Xdemvy |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rayner Intraocular Lenses Limited | $225.09 | 2022-2025 | Rayone Spheric, Rayone Aspheric, Rayone Emv |
| Allergan, INC. | $207.66 | 2019-2022 | |
| Omeros Corporation | $139.60 | 2019-2020 | |
| Harrow Eye, LLC | $123.68 | 2024-2025 | Vevye, Iheezo |
| Thea Pharma INC. | $123.55 | 2023-2024 | Iyuzeh |
| Amgen INC. | $108.19 | 2024-2025 | Tepezza |
| Optos, INC. | $64.55 | 2020 | |
| Horizon Therapeutics Plc | $56.80 | 2021-2022 | |
| Mallinckrodt Enterprises LLC | $54.27 | 2019 | |
| Eyevance Pharmaceuticals LLC | $51.10 | 2019-2023 | Flarex |
| Lensar, INC. | $42.80 | 2025 | Lensar Laser System |
| Shire North American Group INC | $37.32 | 2019 | |
| Dompe US, INC. | $28.89 | 2024 | Oxervate |
| Rxsight INC | $25.77 | 2024 | Rxsight Contact Lens, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
| Eyepoint US, INC. | $19.14 | 2019 | |
| Carl Zeiss Meditec USA, INC. | $17.16 | 2022 | |
| Akorn, INC. | $15.66 | 2020 | |
| Maculogix, INC. | $14.22 | 2020 | |
| Apellis Pharmaceuticals, INC. | $13.75 | 2025 | Syfovre |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Huff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.